Oct 2026· Sleep Science and Practice· Vol 10· 0 citations· 69 references
TL;DR
Sensory-mediated therapy using Viola odorata L. and oral administration of Papaver somniferum L. seeds are effective in the management of primary insomnia, with combination therapy providing additive sustained with less recurrence rate and supporting a graded, personalized integrative treatment approach.
Abstract
Primary insomnia is a common sleep–wake disorder characterized by impaired sleep initiation and maintenance with associated daytime dysfunction, while current pharmacological treatments are often limited by safety and tolerability concerns. This study examined the independent and combined effects of a sensory-mediated non-pharmacological intervention using Viola odorata L. and an oral botanical preparation derived from Papaver somniferum L. seeds in adults with primary insomnia. This exploratory, prospective, randomized, three-arm, component-based integrative trial enrolled 90 participants aged 18–65 years, randomized equally to Viola odorata–based Natūl therapy, Papaver somniferum seed powder, or combination therapy and treated for four weeks. Sleep outcomes—including Insomnia Severity Index (ISI), Pittsburgh Sleep Quality Index (PSQI), daytime dysfunction (VAS), and number of nocturnal awakenings—were assessed at baseline and post-intervention and analysed using a per-protocol framework with non-parametric methods. Recurrence rate has been assessed after three months of treatment. All three interventions were associated with significant improvements across all sleep parameters (all p < 0.001), with large within-group effect sizes (r ≈ 0.86 – 0.89). Between-group comparisons of change scores demonstrated significantly greater improvements with combination therapy compared with either monotherapy (η2 ≈ 0.21–0.26). Viola odorata–based Natūl monotherapy produced improvements comparable to oral Papaver somniferum therapy for most outcomes. No clinically meaningful safety concerns were observed. Sensory-mediated therapy using Viola odorata L. and oral administration of Papaver somniferum L. seeds are effective in the management of primary insomnia, with combination therapy providing additive sustained with less recurrence rate and supporting a graded, personalized integrative treatment approach.
Background Sleep disturbances are common in Alzheimer's disease (AD) and may worsen neuropsychiatric symptoms, caregiver burden, quality of life, and disease progression. Non-pharmacological strategies are increasingly used because long-term hypnotic or antipsychotic treatment may be limited by safety concerns, but the...
Qian-Qian Zhang, Qian Zhou, Meng-Xia Yang et al.· Journal of Alzheimer's Disea...· 0 citations
Background Chronic insomnia is highly prevalent worldwide. First-line treatments are constrained by adverse effects, dependence, and limited accessibility. Traditional mind-body exercises such as Resistance Liuzijue Qigong are safe and feasible. This prospective pilot study preliminarily explored associations between Q...
Chen Hu, Hui-Hui Huang, Meng-Di Zhou et al.· Frontiers in Medicine· 0 citations
Music-based intervention is a potential non-pharmacological approach for insomnia, but its physiological correlates and factors associated with symptom change remain uncertain. This single-arm pilot study explored changes in insomnia symptoms and potential response indicators. Twenty adults with insomnia completed five...
Hao-Ran Wang, Yang Liu, Guo-Chao Li et al.· Journal of Mechanics in Medi...· 0 citations
To evaluate the short-term and sustained associations between stimulant therapy and insomnia severity and sleep quality in newly diagnosed university students with attention-deficit/hyperactivity disorder (ADHD) and pre-existing sleep disturbances.
16-week prospective cohort study.
Single-centre, univ...
S. Nabeel, Alana Holt· BMJ Connections Mental Healt...· 0 citations
The beneficial effects of vornorexant on subjective sleep status and daytime functioning as assessed by using standardized subjective assessment tools in patients with insomnia are supported, and its broad clinical relevance is suggested as a therapeutic option to treat insomnia.
Yusuke Miyazaki, Daiji Kambe, Sayaka Hasegawa et al.· Sleep and Biological Rhythms· 0 citations
Patients reported meaningful improvements with daridorexant 50 mg, including better sleep, reduced nocturia, and enhanced physical, cognitive, and emotional functioning, highlighting the value of free‑text surveys for capturing patient‑centered outcomes.
Dario Arnaldi, D. L. Bliwise, Duygu Alpan et al.· Advances in Therapy· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.